- Home
- SCYX vs BEEM Comparison
SCYX vs BEEM Comparison
Compare SCYX & BEEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCYX
- BEEM
- Stock Information
- Founded
- SCYX 1999
- BEEM 2006
- Country
- SCYX United States
- BEEM United States
- Employees
- SCYX N/A
- BEEM N/A
- Industry
- SCYX Biotechnology: Pharmaceutical Preparations
- BEEM Semiconductors
- Sector
- SCYX Health Care
- BEEM Technology
- Exchange
- SCYX Nasdaq
- BEEM Nasdaq
- Market Cap
- SCYX 28.5M
- BEEM 23.4M
- IPO Year
- SCYX 2014
- BEEM N/A
- Fundamental
- Price
- SCYX $0.82
- BEEM $1.89
- Analyst Decision
- SCYX
- BEEM Strong Buy
- Analyst Count
- SCYX 0
- BEEM 4
- Target Price
- SCYX N/A
- BEEM $5.33
- AVG Volume (30 Days)
- SCYX 176.2K
- BEEM 1.4M
- Earning Date
- SCYX 08-07-2025
- BEEM 08-12-2025
- Dividend Yield
- SCYX N/A
- BEEM N/A
- EPS Growth
- SCYX N/A
- BEEM N/A
- EPS
- SCYX N/A
- BEEM N/A
- Revenue
- SCYX $2,630,000.00
- BEEM $41,099,000.00
- Revenue This Year
- SCYX $463.61
- BEEM N/A
- Revenue Next Year
- SCYX $310.80
- BEEM $38.51
- P/E Ratio
- SCYX N/A
- BEEM N/A
- Revenue Growth
- SCYX N/A
- BEEM N/A
- 52 Week Low
- SCYX $0.66
- BEEM $1.33
- 52 Week High
- SCYX $2.29
- BEEM $6.80
- Technical
- Relative Strength Index (RSI)
- SCYX 57.87
- BEEM 63.62
- Support Level
- SCYX $0.67
- BEEM $1.61
- Resistance Level
- SCYX $0.75
- BEEM $1.78
- Average True Range (ATR)
- SCYX 0.04
- BEEM 0.13
- MACD
- SCYX 0.01
- BEEM 0.03
- Stochastic Oscillator
- SCYX 93.53
- BEEM 100.00
About SCYX SCYNEXIS Inc.
SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.
About BEEM Beam Global
Beam Global produces sustainable technology for electric vehicle (EV) charging, outdoor media, and energy security, without the construction, disruption, and costs of grid-tied solutions. Its products are founded upon its patented EV ARC and Solar Treelines and include BeamTrak patented solar tracking, and ARC Technology energy storage, along with EV charging, outdoor media, and disaster preparedness packages. From start to finish, the company develops, patents, designs, engineers, and manufactures renewably energized products that help the environment, empower communities, and keep people moving.